C9 and amyotrophic lateral sclerosis: Apart from measurements that are associated with the refractoriness of the nerve, no other standard or composite excitability measurements were found to differ between the C9+ and C9− ALS patients, including the SDTC and superexcitability that have diagnostic potential [13].